News & Updates Archives

7MED Welcomes Strategic Investment from PVP Ventures to Accelerate Healthcare Innovation

8th September 2025Prem Malhotra Blog News & Updates

_{Strengthening Our Mission to Deliver Quality Renal and Urology Care Across India}

A New Chapter fo7MED

We are proud to announce that PVP Ventures Limited, a forward-looking investment company, has acquired a 41.23% strategic stake in 7Med India Pvt. Ltd. and Epitome Group of Hospitals. This investment marks a significant milestone in our journey and further empowers our commitment to accessible, high-quality, and technology-driven healthcare.

The transaction, announced on August 29, 2025, lays the foundation for long-term collaboration, with plans to grow the partnership.

Who We Are: The 7MED Impact

Founded with the mission of transforming renal care in India, 7MED and Epitome Hospitals operate a network of:

22 dialysis centers (both standalone and within hospitals)
4 super-specialty hospitals
Coverage across six Indian states, focused on nephrology, urology, and kidney transplantation

With a team of 450+ medical professionals, we’ve proudly conducted over 1 million dialysis procedures, making us a trusted name in advanced kidney care.

About Our Strategic Partner: PVP Ventures

PVP Ventures is actively building a technology-led healthcare ecosystem, investing in high-potential healthcare businesses with strong clinical foundations. Their portfolio spans oncology, diagnostics, genomics, dialysis, teleradiology, and senior care. Their focus on Tier II and Tier III cities aligns with our own mission to bridge the healthcare access gap in underserved markets.

This investment in 7MED is part of PVP’s broader strategy to build a “house of healthcare brands,” fueling innovation and scale in India’s health infrastructure.

Shared Vision: Growth and Impact

With this partnership, 7MED aims to:

Expand operations to new geographies
Enhance clinical capabilities through technology and process innovation
Invest in infrastructure, training, and digital tools
Scale our services with a target of 5X EBITDA growth over the next four years

We believe this collaboration will bring significant value not only to our organization but more importantly—to the millions of patients we serve.

Leadership Perspectives

Gaurav Davda, Head of M&A and Strategy at PVP Ventures, commented:

“This transaction is a key milestone in our journey to build a powerful house of healthcare brands with a focus on Tier II and Tier III markets. We are excited to partner with 7MED, a company that aligns with our values and vision for healthcare access and innovation.”

Dr. Vijay Kher, Chairman of Epitome Hospitals and shareholder in 7MED, added:

“This partnership allows us to scale our mission of patient-centric kidney care, leveraging PVP’s strategic insights and investment to improve outcomes across India.”

7MED in the News

Our strategic partnership with PVP Ventures has been featured in leading media outlets:

7Med India has collaborated with AIIMS, Rishikesh

6th April 2021Team 7Med Blog News & Updates

In our efforts to further our mission of providing high quality dialysis treatments, 7Med India has collaborated with AIIMS, Rishikesh.

7Med was established in Dec 2013 under the visionary leadership of co-founders Mr. Vikas Verma, Mr. Mayank Sharma and Dr. Rakesh Thakur. We have been operational since 2014 & since then have provided almost 1,000,000 treatments to 5000+ patients across 20+ different locations in North India. And now our services are also available at AIIMS, Rishikesh.

We have firmly established ourselves as renal care pioneers. Our team of highly skilled & experienced medical professionals expertise in providing renal care services and they have been doing so with great success at all our clinics.

Every 7Med Kidney Care clinic is designed keeping the patient at its core. Apart from providing high quality dialysis treatments the 7Med team educates & trains the patients to become knowledgeable about dialysis and self care. This is how we empower patients to lead an effortlessly healthy life.

AIIMS, Rishikesh with their mission of establishing a center for excellence in healthcare is the quintessential partner for 7Med India as they uphold and abide by the same values and standards on the rostrum of which 7Med stands.

As a part of this collaboration, 7Med India has established a state of the art Dialysis Clinic at AIIMS, Rishikesh premises. The center was inaugurated by the honourable Minister of State for Health and Family Welfare, Shri. Ashwani Kumar Choubey on 1st of April, 2021. This center has 30 machines and is capable of carrying out 2500+ haemodialysis treatments per month. Apart from regular haemodialysis, we will also be carrying out advanced renal care treatments like SLED (Sustained Low Efficiency Dialysis) & OHDF (Online Haemodiafiltartion) at this center to ensure all renal care requirements of the region are fulfilled without fail.

With 7Med, patients have always got more than just a dialysis service provider. They get a caregiver and a partner that stands by their side, be it night or day, aiding and enabling them to live an unencumbered happy life.

And with this partnership with the august & illustrious institute of AIIMS (Rishikesh), we will keep delivering high quality services with unwavering dedication to the wonderful people of the magnificent state of Uttarakhand.

7Med in talks for Series B Funding – Covered by VCCircle

10th January 2020VC Circle News & Updates

VCCircle , India’s leading source of financial news, covered 7Med & its efforts to secure Series B funding.

Link to the original article published in VCCircle: https://tinyurl.com/v9d8mah

Read the complete article below.

“Dialysis clinic chain 7Med India Pvt. Ltd, which had received investment from a European company two years ago, is looking for fresh capital to grow in a market that is highly unregulated but has recorded some private equity action.

Vikas Verma, co-founder and director at 7Med, told VCCircle the company wants to raise Rs 90 crore ($13 million) in its Series B funding round.

Talks are on with potential investors, he said, but didn’t disclose their identities and other aspects citing confidentiality issues.

Gurugram-based 7Med was founded in 2013 by Verma, Rakesh Thakur and Mayank Sharma. It had received funding from Russian dialysis firm Nefromed two years ago. Nefromed had invested through its India arm Dicopa.

The three founders were earlier associated with German dialysis services provider Fresenius Medical Care AG, which has a significant presence in India as well. Fresenius had acquired Tata Capital Healthcare Fund-backed dialysis services company Sparsh Nephrocare in 2016.

7Med, which ties up with hospitals to set up its clinics within their premises, had around five centres at the time of Nefromed’s investment. The number of centres has now risen to 21.

The company claims it conducts 7,500 treatments a month, and aims to have up to 100 centres in three years’ time. Verma said the company is looking to enter India’s eastern and northeastern regions next year and then establish its presence in the southern region.

Verma also said the company will launch its first standalone centre in Delhi by March as it seeks to build on the traction it has gained. A standalone store costs around Rs 15 crore, nearly ten times as much as a clinic within a hospital, but the company feels its own centres would help it build its brand.

The company has also won its first project to work with the government-backed All India Institute of Medical Sciences hospital in Delhi. This could help boost its presence in the country.

The government in its Budget for 2016-17 had noted that India gets about 2,20,000 new patients of end-stage renal disease every year and that the annual expense burden on each patient is more than Rs 3,00,000. Hence, the government had proposed to start a National Dialysis Services Programme to provide renal-care services in district hospitals.”

By: Joseph Rai, VCCircle